We received fabulous feedback, with responses from at least 15 industry executives across global pha...
Read moreDifferences in market access and reimbursement processes are an important factor in determining the ...
Read moreThis resolution includes proposed reforms to the market access (including pricing) landscape designe...
Read more"Market Access" describes activities and processes that pharmaceutical and biotech companies underta...
Read morePrescription drug prices in the US rank among the highest in the world and the US spent $1220 on ph...
Read moreNHS England is developing a new Commercial Framework, outlining potential opportunities for commerci...
Read moreMaximising the cost-saving potential of biosimilars remains a topic of much interest to payers and p...
Read moreThis study investigates how gaps in the current evidence are linked to access restrictions and mitig...
Read morePharmaceutical companies are incorporating payer / HTA needs into their clinical and commercial laun...
Read more